首页> 外文期刊>Journal of Infectious Diseases >Challenge Pools of Hepatitis C Virus Genotypes 1–6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver-Chimeric Mouse Models
【24h】

Challenge Pools of Hepatitis C Virus Genotypes 1–6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver-Chimeric Mouse Models

机译:丙型肝炎病毒基因型1-6原型菌株的挑战池:黑猩猩和人类肝嵌合小鼠模型中的复制适应性和致病性。

获取原文
获取原文并翻译 | 示例
           

摘要

Chimpanzees represent the only animal model for studies of the natural history of hepatitis C virus (HCV). To generate virus stocks of important HCV variants, we infected chimpanzees with HCV strains of genotypes 1–6 and determined the infectivity titer of acute-phase plasma pools in additional animals. The courses of first- and second-passage infections were similar, with early appearance of viremia, HCV RNA titers of >104.7 IU/mL, and development of acute hepatitis; the chronicity rate was 56%. The challenge pools had titers of 103–105 chimpanzee infectious doses/mL. Human liver-chimeric mice developed high-titer infections after inoculation with the challenge viruses of genotypes 1–6. Inoculation studies with different doses of the genotype 1b pool suggested that a relatively high virus dose is required to consistently infect chimeric mice. The challenge pools represent a unique resource for studies of HCV molecular virology and for studies of pathogenesis, protective immunity, and vaccine efficacy in vivo.
机译:黑猩猩是研究丙型肝炎病毒(HCV)自然史的唯一动物模型。为了产生重要的HCV变体的病毒原种,我们用基因型1-6的HCV株感染了黑猩猩,并确定了其他动物急性期血浆库的感染力滴度。第一次和第二次感染的过程相似,早期出现病毒血症,HCV RNA滴度> 10 4.7 IU / mL,并发展为急性肝炎。慢性病率为56%。攻击池的滴度为10 3 –10 5 黑猩猩感染剂量/ mL。人类肝嵌合体小鼠接种基因型1-6的攻击病毒后感染了高滴度病毒。用不同剂量的基因型1b库进行接种研究表明,要持续感染嵌合体小鼠,需要相对较高的病毒剂量。挑战池代表了一种独特的资源,可用于研究HCV分子病毒学以及体内的发病机理,保护性免疫和疫苗功效。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2010年第9期|p.1381-1389|共9页
  • 作者单位

    Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland|Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre, and Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen Copenhagen, Denmark;

    Center for Vaccinology, Ghent University and Hospital Ghent, Belgium;

    Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland;

    Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, Maryland;

    Divisions of Viral Products, Center for;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号